Does Etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? A case report

Secondary hyperparathyroidism (SHPT) in dialysis is common. A young man on chronic hemodialysis with SHPT developed pancytopenia with resistant anemia requiring transfusions. A bone marrow biopsy showed grade 3 fibrosis, depleted cellularity, osteosclerosis, and decreased myelopoiesis. He initiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Panuccio, Vincenzo Antonio, Tripepi, Rocco, Postorino, Adele, Greve, Bruna, Sabattini, Elena, Oliva, Esther Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995371/
https://www.ncbi.nlm.nih.gov/pubmed/36910010
http://dx.doi.org/10.3389/fmed.2022.1050062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995371/
https://www.ncbi.nlm.nih.gov/pubmed/36910010
http://dx.doi.org/10.3389/fmed.2022.1050062

Ejemplares similares